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ABSTRACT
Background There has been an increasing interest in 
studying the potential benefits of so- called complementary 
and alternative approaches for pain management, such 
as hypnosis and mindfulness- based interventions. More 
recently, researchers have been interested in studying 
the effects of spiritual practices on pain experience 
as well. These practices may increase pain tolerance, 
result in a positive re- appraisal of pain and influence 
other psychological variables that are known to be 
associated with pain experience. The purpose of this 
study is to evaluate and compare the immediate effects 
of self- hypnosis, mindfulness meditation, and a spiritual 
intervention relative to a control condition for increasing 
pain tolerance and reducing pain intensity and pain- related 
stress, in response to experimental painful stimulation.
Methods and analysis Recruitment is anticipated to 
start in November 2020. This is a randomised quantitative 
experimental mixed- design repeated- measures study with 
three assessment points: baseline (T0), pre- test (T1) and 
post- test (T2). Eligible healthy adults will be randomised 
to one of the four study conditions. Interventions will be a 
20- minute audio- guided practice of either self- hypnosis, 
mindfulness meditation, or Christian prayer. Participants in 
the control group will not be instructed to use any specific 
strategy during the painful stimulation. Participants will 
be submitted to a first cycle of Cold Pressor Arm Wrap. 
They will then listen to a 20- minute audio recording 
inducing one of the three interventions, or, in the case 
of the control group, to a 20- minute audio recording of 
text from a natural history textbook. Primary outcomes 
are pain intensity and pain tolerance. Pain- related stress 
as measured by salivary cortisol level and heart rate 
variability are secondary outcomes.
Ethics and dissemination This study was approved by 
ISPA—University Institute’s internal Ethics Committee 
for Research on 3rd December 2018 (reference 
I/010/12/2018). Findings will be published in peer- 
reviewed indexed journals and presented at conferences.
Trial registration number  ClinicalTrials. gov registry 
(NCT04491630). Stage: pre- results.
INTRODUCTION
Background and rationale
Pain is a universal experience.1 It is also a 
homeostatic and adaptive mechanism, essen-
tial for survival.2–4 Without pain, an injury 
or serious health condition could go unno-
ticed, potentially leading to the death of the 
organism.5 6
At the same time, pain is also an unpleasant 
and distressing experience that can under-
mine well- being,7 8 and is a primary reason for 
seeking medical care.9 Although minor acute 
pain can be readily managed, moderate- to- 
severe acute pain may require a level of care 
that may not be available in many treatment 
settings.10 Even when standard treatments 
are available, a large number of patients 
Strengths and limitations of this study
 ► This is an innovative study comparing the effects of 
three 20- minute interventions (self- hypnosis, mind-
ful meditation, Christian prayer) relative to a control 
group of healthy participants experiencing experi-
mentally induced pain.
 ► Standard Protocol Items Recommendations for 
Interventional Trials and Consolidated Standards of 
Reporting Trials checklist guidelines were followed, 
to ensure quality in all aspects of study planning, 
execution and reporting.
 ► Strengths of the study include the random allocation 
and specific efforts to limit bias (blinded outcome 
assessment, standardisation of intervention and col-
lection of concomitant treatment).
 ► The primary limitation of this study is the limited 
generalisability of potential findings to populations 
with chronic pain and experiencing acute pain in 
natural context.
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continue to report severe acute pain.11 12 Relatedly, about 
20% of patients with acute pain are not satisfied with 
the pain treatment provided to them.13 If not appropri-
ately treated, severe acute pain is known to contribute 
to negative cardiovascular, immunological, gastrointes-
tinal, renal, muscular, sleep and psychological compli-
cations.10 14 The presence of severe acute pain also puts 
patients at risk for the development of chronic pain.10 14 
All of this evidence supports the importance of patient 
access to effective acute pain management treatments.
Given its subjective and complex nature, effective pain 
management frequently requires more than analgesics.14 
Pain is a multidimensional experience that cannot be 
merely explained by the physiological mechanisms that 
underline its experience.3 15 16 Pain is influenced by a 
number of biological (eg, physiological aetiology, severity 
of physical damage), psychological (eg, pain- related 
beliefs and pain coping responses), social (eg, social 
support) and spiritual/religious (eg, meaning in life, 
religiosity) factors.17–25 Not surprisingly, multidisciplinary 
treatment programmes that address the multifaceted 
nature of pain, including its psychosocial dimensions, are 
more effective than unimodal treatments that focus only 
on biomedical factors.26–28 Given this evidence, multidis-
ciplinary treatments that include instruction and encour-
agement in the use of psychological, social and spiritual 
coping may be useful.14 29
Two psychological coping responses that are commonly 
taught in such programmes are self- hypnosis (SH) and 
mindfulness meditation (MM). Both SH and MM have 
evidence supporting their efficacy with acute, chronic 
and experimentally induced pain.30–40 Both interventions 
can be used independently or together, and have been 
shown to: (a) induce brain states that are hypothesised 
to be associated with a decrease in the processing of noci-
ceptive input as well as adaptive cognitive processes such 
as acceptance and openness to suggestion; and (b) affect 
pain- related cognitive content—such as pain- related 
beliefs and cognitive pain coping responses.37 38 40 41 Both 
SH and MM have also been shown to have weak- to- strong 
effects on pain intensity and on pain tolerance,31 32 35 38 39 
with the magnitude of the effects varying as a function 
of: (a) previous experience in using either of these strat-
egies (being a novice vs being a long- term practitioner 
of MM); (b) outcome expectancies; (c) hypnotic suggest-
ibility (for SH), (d) trait absorption and (e) pretreat-
ment (pain) acceptance.38 40 42–44 It is also possible that, 
as Tang et al have hypothesised,45 dispositional or base-
line mindfulness—that is, a long- lasting and pre- existent 
tendency towards mindfulness of consciousness—affects 
brain processing, the ability to practice MM, as well as the 
effects of MM. In support of this hypothesis, a recent study 
examined the moderation effect of baseline mindfulness 
on the effects of MM, cognitive therapy and mindfulness- 
based cognitive therapy for chronic low back pain.46 The 
authors found that non- reactivity (ie, a facet of base-
line mindfulness that refers to active detachment from 
negative emotions and thoughts), but not observation 
(ie, a facet of baseline mindfulness that refers to how 
one sees, feels, and perceives the internal and external 
world around oneself and selects the stimuli requiring 
one’s attention), moderated the effects of both MM 
and mindfulness- based cognitive therapy. Those partici-
pants with lower baseline non- reactivity reported greater 
improvement in physical function as a result of MM, while 
those with higher baseline non- reactivity reported greater 
improvement in mindfulness- based cognitive therapy. 
However, we are not aware of any other studies that have 
examined the moderating role of baseline mindfulness 
on the effects of MM.
Recent research on the role that spirituality (the 
extent to which an individual searches for meaning and 
purpose in life, as well as feelings of transcendence and 
of being connected to a higher power)20 and religiosity 
(the degree of an individual’s engagement with the 
belief system and with individual and group practices of 
a given religion)20 —have on pain experience suggests 
that at least some individuals spontaneously engage in 
spiritual and religious practices when experiencing pain 
as a way to cope.47–49 Moreover, higher levels of spiritu-
ality and religiosity (S/R) are hypothesised to have a 
buffering effect against stressors.47 50 51 Both spiritual (eg, 
spirituality- based meditation) and religious practices (eg, 
prayer) that might reduce stress may account for these 
buffering effects.50 Although there is a growing interest in 
evaluating the potential benefits of spiritual and religious 
practices on pain experience,52–57 and on identifying the 
mechanisms that explain their buffering effects on pain 
experience,58 to date, only a limited number of studies 
have focused on these issues. This is especially true for 
religiosity and for religious practices. Findings from the 
limited number of studies that have been conducted 
suggest that S/R and spiritual and religious practices 
may play a role in influencing pain (eg, pain tolerance 
and pain intensity) and pain- related outcomes (eg, pain- 
related distress).19 20 47 50 54–56 59–61 These practices are 
thought to increase pain tolerance, determine a positive 
re- appraisal of pain and modulate psychosocial variables 
(eg, meaning of pain, beliefs and attributions, coping and 
mood) that are associated with pain experience.22 47 60 62
However, these studies have focused primarily on clin-
ical populations with chronic pain. There are only limited 
findings regarding the effects of S/R and religious prac-
tices, such as Christian prayer (CP), on acute pain.57 63 
One of the few studies examining the effects of being or 
not being religious and of religious practices on acute 
experimentally induced pain was conducted by Wiech 
et al.57 These authors presented a group of 12 practising 
Christian Catholics and a group of 12 self- described non- 
religious participants to either a religious stimulus (ie, 
looking at an image of the Virgin Mary) or a non- religious 
stimulus (ie, looking at a matched image without religious 
connotation). Statistically significant and large condition 
and Group X Condition interaction effects were found, 
suggesting that the religious practice of contemplating a 
religious image has an effect on pain intensity, and that 
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the magnitude of this effect might be moderated by indi-
viduals’ religion and/or religiosity.
Research focusing the effects of religious practices 
(eg, prayer) on pain, and on the mechanisms explaining 
the effects of these practices, is a critical, understudied, 
next step in this field of research. The findings from this 
research could inform both clinicians and the public 
about how religious practices may be used to cope more 
effectively with pain. Moreover, a comparison of the 
effects of SH, MM, and religious practices on pain expe-
rience and pain- related- outcomes, and understanding 
for whom these pain management practices work, may 
also inform the relative utility of these strategies for pain 
self- management ensuring their optimal implementa-
tion. This study seeks to address knowledge gaps in this 
area by comparing the immediate effects of SH, MM and 
religious practices on pain- related outcomes relative to a 
control condition, and assessing what individual baseline 
characteristics moderate the effects of SH, MM and reli-
gious practices on pain- related outcomes.
Study aims and hypotheses
The primary aim of this study (aim 1) is to compare the 
immediate effects of SH, MM and CP, relative to a control 
group (CN), for increasing pain tolerance and reducing 
pain intensity and pain- related stress, in response to 
experimental painful stimulation in a sample of healthy 
volunteers. Based on the research performed to date, 
reviewed above, we hypothesise that participants who 
listen to audio recordings that facilitate the use of one 
of the three coping responses—SH, MM and CP—will 
evidence greater pain tolerance and lower levels of pain 
intensity and pain- related stress than participants in the 
CN condition. Although one previous experimental study 
has directly compared the effects of a 3- minute practise 
of MM and SH on acute pain,64 no research to date has 
directly compared all three (ie, SH, MM and CP). Thus, 
we did not have any hypotheses about possible between- 
strategy differences on pain outcomes. However, we do 
plan to evaluate possible between- group differences to 
examine this.
An exploratory aim of this study (aim 2) is to iden-
tify possible shared and unique predictors of response 
to the three treatment conditions. The possible predic-
tors we plan to test include sex, age, religious affiliation, 
hypnotic suggestibility, baseline mindfulness, acceptance, 
pain- related beliefs, religiosity, trait spirituality, previous 
experience with SH, MM and CP, outcome expectancies 
and trait absorption. We will test for both shared and 
treatment- specific prediction effects for each of these vari-
ables on all three study outcomes (ie, pain tolerance, pain 
intensity and pain- related stress), assessed via three vari-
ables (ie, pain tolerance, pain intensity and pain- related 
stress that will be assessed by two psychophysiological 
indicators: heart rate variability (HRV) and cortisol level). 
The aim 2 hypotheses are to determine if: (a) the effects 
of SH on pain- related outcomes will be predicted by trait 
absorption, hypnotic suggestibility, outcome expectations 
(OE), and previous experience of SH; (b) the effects of 
MM on pain- related outcomes will be predicted by trait 
absorption, baseline mindfulness, acceptance, pain- 
related beliefs, catastrophising, OE, and previous experi-
ence of MM; and that (c) the effects of CP on pain- related 
outcomes will be predicted by religious affiliation, S/R, 
trait absorption, acceptance, pain- related beliefs, cata-
strophising, OE, and previous experience of CP. Due to 
the large number of planned analyses (see the Statistical 
analysis plan section, described later), and because this is 
the first study to our knowledge that has compared these 
three approaches and evaluated treatment moderators in 
the same study, we view the tests of shared and unique 
predictors of outcome as exploratory.
METHODS AND ANALYSIS
Study design
The current study will use a randomised quantitative 
experimental mixed- design repeated- measures design. 
Figure 1 shows the overall flow of study procedures, while 
table 1 provides a brief structured summary of the study. 
This is a four- arm parallel prospective experimental 
controlled study, with one CN and three experimental 
conditions (SH, MM and CP), using the Cold Pressor 
Arm Wrap (CPAW) to induce pain.65 The effects of the 
treatment conditions on the three pain- related outcomes 
will be compared. All participants will be assessed at three 
assessment points: (a) baseline (T0) to assess baseline 
characteristics, pre- intervention (before randomised 
allocation and before the first CPAW trial); (b) pre- test 
(T1), pre- intervention, after randomised allocation and 
in response to the first CPAW trial; and (c) post- test (T2), 
Figure 1 Flow of study procedures. CN, control group; MM, 
mindfulness meditation; SH, self- hypnosis.
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immediately after the treatment condition procedures (ie, 
SH, MM, CP or CN) and the second CPAW trial. The study 
results will be reported according to the Consolidated 
Standards of Reporting Trials (CONSORT) guidelines for 
trials of non- pharmacological interventions.66
Participants
The participants will be a non- clinical sample of 196 
healthy adult participants (approximately 50% men). 
Sample size was determined using a priori power calcula-
tion using G*Power (V.3.1), considering a mixed- design 
repeated- measures design, a default pre–post correlation 
across the pre- test and post- test of 0.5, a small- to- medium 
effect size (Cohen’s f) of 0.15 for a time×condition inter-
action effect, a two- sided α of 0.05 and a power of 0.95. 
Cohen’s f was set at 0.15 based on the results of previous 
research with both clinical and non- clinical populations 
supporting the anticipated small- to- large effects of CP 
(0.34<f<0.43), SH (0.15<f<0.37), and MM (0.45<f<4.54) 
in pain intensity and tolerance.31 32 35 38 53 57 We plan to 
enrol 248 participants in order to ensure a final sample 
size of 196 completers (49 per group), assuming a conser-
vative 20% dropout rate.
Inclusion criteria are: (a) being at least 18 years old; 
(b) able to read, speak and understand Portuguese; and 
(c) willing to be randomly assigned to all four condi-
tions (regardless of participant’s own religious affilia-
tion). Exclusion criteria include: (a) reporting history of 
musculoskeletal problems, cancer, heart disease, stroke, 
epilepsy, diabetes or Raynaud syndrome; (b) having an 
open wound, cut or fracture in any of the upper limbs; 
(c) self- reported alcohol or substance dependence; and 
(d) cognitive or physical impairment, or severe psychopa-
thology that could prevent participation.15
Study setting, recruitment, screening and enrolment
This study will be conducted at the William James Center 
for Research, at ISPA–University Institute, Lisbon, 
Portugal (the host institution). All participants will be 
non- clinical healthy adults enrolled from the host institu-
tion internal and external participant pools. Procedures, 
such as informed consent, assessments, experimental 
trials and interventions, will be conducted in person and 
held at one of the host institution’s labs.
Recruitment is anticipated to start in November 2020. 
Prospective participants will be sent an approach letter 
and contacted via telephone 1–2 weeks after mailing. 
Interested participants will be screened, during a tele-
phone call, by research staff members to determine eligi-
bility. Inclusion and exclusion criteria will be assessed via 
self- report, and reasons of ineligibility will be collected 
for purposes of adhering to the CONSORT standards.66
Prospective participants who are eligible and inter-
ested to participate will be invited to participate in an 
informed consent process that will be conducted in 
person by a research staff member. These participants will 
be given a full description of the study aims and proce-
dures, as well as the opportunity to clarify any doubts or 
concerns. Participants will be assured of the confidential 
and voluntary nature of participation, and that they can 
discontinue participation at any moment. On agreement 
Table 1 Structured summary of the study
Data category Information32
Registry and trial 
identifying number
ClinicalTrials.gov (NCT04491630)
Date of registration 
in primary registry
29 July 2020
Source of funding Foundation BIAL Grant for Scientific 
Research (grant number 188/18)
Sponsor William James Center for Research, 
ISPA—ISPA–University Institute
Contact for public 
and scientific 
queries
AFV, William James Center for 
Research, ISPA–University Institute, 
Rua Jardim do Tabaco, no. 34, 1149-




COping With PAin Through Hypnosis, 







Healthy participants; experimentally 
induced acute pain
Intervention(s) Self- hypnosis; mindfulness meditation; 
Christian prayer; control
Key inclusion and 
exclusion criteria
Inclusion criteria: (a)18 years old or 
older; (b) read, speak and understand 
Portuguese; (c) willing to be randomly 
assigned to all four conditions
Exclusion criteria: (a) history of 
musculoskeletal problems, cancer, 
heart disease, stroke, epilepsy, diabetes 
or Raynaud syndrome; (b) open wound, 
cut or fracture in any of the upper limbs; 
(c) alcohol or substance dependence; 
(d) cognitive or physical impairment, 




Intervention model: parallel assignment
Masking: single blind




Target sample size 196
Recruitment status Study recruitment began on November 
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to participate, participants will then be asked to sign 
an informed consent form. Enrolled participants will 
complete baseline assessment (T0) in person.
Those individuals who decline to participate will be 
asked to provide a reason for their decline. They will also 
be asked basic demographic information—such as sex 
and age—to enable comparison between the study partic-
ipants and eligible prospective participants who decline 
to participate.
Randomisation, allocation and blinding
After enrolment and baseline assessment, participants 
will be randomly assigned to one of the four conditions 
(SH, MM, CP or CN). Participants will be randomised 
in stratified blocks to ensure that subjects with each sex, 
religious affiliation, and previous experience in SH, 
MM and CP have the same chance of being allocated to 
one of the four conditions. Randomisation process will 
be performed using a computerised random sequence 
generator.
Participants will be blind to the study hypotheses. 
During informed consent, in order to maximise the 
odds that participants will have similar outcome expec-
tancies regarding the different experimental conditions, 
prospective participants will be told that they will listen 
to an audio recording that previous research studied as 
potentially helpful for pain management, and that the 
purpose of the study is to assess the effects of this audio 
recording on discomfort associated with the sensation 
of coldness. Participants will also be instructed not to 
disclose details of the content of the audios they receive 
to the experimenter. The experimenter who will conduct 
assessments and administer the audio- recorded interven-
tions will be blind to both the condition to which subjects 
are assigned and the study hypotheses. The research staff 
member responsible for participants’ randomisation will 
be blind to identifying information and to the code iden-
tifying each condition.
Trial design
Participants’ baseline characteristics will be assessed at 
baseline (T0), immediately after consent process. Pain- 
related outcomes will be assessed both at pre- test assess-
ment (T1) and post- test assessment (T2).
All participants will be provided a pre- test CPAW trial 
to allow for the pre- test (T1) assessment. The CPAW65 is 
an effective alternative approach to the traditional cold 
pressor test.15 It is a secure experimental method for 
inducing systemic stress and pain, involving attaching 
an arm wrap composed of MRI- safe gelpacs cooled to 
1°C−3°C to the forearm and hand of the individual. The 
CPAW has been shown to result in increases in post- test 
cortisol releases.65
Baseline cortisol level will be measured, and baseline 
HRV will be calculated based on a 5 min resting period 
before pre- test. The participants will have the cold arm 
wrap attached at 3°C±0.5°C to the forearm and hand for 
as long as they tolerate the stimuli (maximum of 5 min). 
Pre- test (T1) assessment will be performed during (heart 
rate and pain tolerance) and after (salivary cortisol 
sample and pain intensity) the CPAW.
A second CPAW cycle will take place after a 20- minute 
rest interval, followed by a 20- minute interval during 
which participants will either listen to SH, MM, or CP 
induction/instruction or a natural history (CN) audio 
recording, which has been previously validated as a 
control condition.67 This interval enables: the time for 
the exposure to SH, MM or CP; and to control for diffuse 
noxious inhibitory control.68 The second experiment—a 
second CPAW cycle lasting until subjects no longer 
tolerate the pain (up to a maximum of 5 min)—includes 
a post- test (T2) assessment similar to T1. Participants will 
also listen to a 5- minute recording of SH, MM, CP induc-
tion/instruction or a natural history audio recording 
(CN) during the second CPAW cycle.
Experimental conditions/study interventions
All of the interventions will be equivalent in terms of time 
and structure. All four will be presented via 20- minute 
audio- recordings just before the second CPAW cycle, 
which will teach them and allow them to practice the 
three active responses (SH, MM or CP) or provide them 
with the control audio recording (CN). Following this 
and during the second CPAW cycle, the participants in 
the active conditions will be invited to practise the strategy 
they were taught with the 20- minute audio recording, 
while also listening to a 5- minute recording to assist with 
this practice. The participants in the control condition 
will listen to a 5- minute natural history audio recording 
during the second CPAW cycle. All audio recordings will 
be audible only to the participant (ie, the researcher 
conducting the procedures will be blind to treatment 
condition).
To promote participant retention and adherence to 
intervention and assessments, a careful explanation 
of the study’s potential social and academic relevance 
and benefits will be given to all participants during the 
consent process. Also, both the trials and assessments 
will be scheduled according to participants’ preferences, 
and reminder telephone calls prior to the trial and assess-
ments session will be made.
Intervention content
An in- depth description of the rationale for the selection 
of SH and MM is provided by Jensen,34 and by Williams 
et al.41 Both SH and MM are well- established commonly 
used approaches that have evidence supporting their 
effectiveness with acute, chronic and experimentally 
induced pain.34 36 38 CP, on the other hand, is one of the 
S/R practices that has preliminary evidence supporting 
its effects on reducing pain.59
Specific scripts for each intervention will be developed 
based on theoretical and empirical foundations. Scripts for 
SH and MM will be developed by research team members 
(MJ and MD, respectively) who are experts in each of these 
interventions as applied to pain management. These scripts 
S
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will then be translated, adapted into Portuguese, by two inde-
pendent bilingual translators and back translated by a third 
independent bilingual translator. Any discrepancies in the 
translation will be resolved during a meeting of experts in 
these psychological interventions and pain management. A 
final version will be obtained through a consensus of these 
experts. The back- translation of the final version of the scripts 
will be reviewed and approved by MJ and MD to ensure that 
the content of the scripts is as originally intended. To ensure 
that the individuals in our population understand these 
scripts, a pilot test will be held in a sample of 10 Portuguese 
adults. Scripts for CP will be adapted from the existing online 
biblical meditations from the Society of Jesus ( www. passo- 
a- rezar. net), by a research team member (AF- V) which will 
closely collaborate on the CP script adaptation with a Portu-
guese CP expert from the Society of Jesus.
SH condition
After the 20- minute rest interval between the first cycle of 
CPAW and the second CPAW cycle, participants assigned 
to this condition will listen to a 20- minute recording with 
instructions of SH adapted from one of our team member’s 
(MJ) proposed model.22 First, the audio recording will intro-
duce and orient the participant to SH. Then instruction 
in SH will be provided, including: (a) how to self- induce a 
hypnotic induction; (b) specific self- suggestions for comfort 
and ability to manage intense sensations; and (c) post- 
hypnotic suggestions that the participant will be easily able to 
use these hypnotic strategies on their own at a later time (ie, 
in this case, during the CPAW procedures that will follow). A 
second 5- minute audio- recording with instructions to guide 
the participant in SH will be provided during the second 
cycle of CPAW.
MM condition
After the 20- minute rest interval between the first cycle of 
CPAW and the second CPAW cycle, participants in the MM 
condition will listen to a 20- minute recording with instruc-
tions in the use and application of Vipassana MM,69 adapted 
from the manual developed by one of our team members 
(MD).70 First, the audio recording will focus on introducing 
the idea of attention to their breath, and of non- judgemental 
monitoring and acceptance of the all events and stimuli. 
Then a guided MM (body scan) experience will be provided. 
A second 5- minute audio recording with instructions to facili-
tate the MM (body scan) experience taught in the first audio 
recording will be provided during the second cycle of CPAW.
CP condition
After the 20- minute rest interval between the first cycle of 
CPAW and the second CPAW cycle, participants in this condi-
tion will listen to a 20- minute recording with CP instructions. 
These instructions will be adapted from the existing online 
biblical meditations from the Society of Jesus ( www. passo- 
a- rezar. net). First, the audio recording will introduce and 
orient the participant to CP. Then, a text of the New Testa-
ment of the Bible will be read two times, followed by a brief 
suggestion of prayer. A second 5- minute audio recording 
with instructions to facilitate the CP experience taught in 
the first audio recording, including the recording of a text 
of the Bible followed by a brief suggestion of meditation and 
relaxing music, will be provided during the second cycle of 
CPAW.
CN condition
Participants assigned to the control condition will participate 
in all of the assessments and experimental tasks, but will not 
be instructed to use any particular coping strategy to cope 
with the aversive stimulus provided by the CPAW procedure. 
After the rest interval between the first cycle of CPAW and 
the second CPAW cycle, participants in the CN condition 
will listen to a 20- minute natural history audio recording.67 
The option for this recording is supported by: (a) previous 
research showing that individuals who were asked to listen to 
it found it to be a neutral, yet relaxing, passage; (b) the use 
of this passage as an effective control condition in previous 
studies.71 72 A 5- minute natural audio recording will be 
provided during the second cycle of CPAW.
Study variables
Table 2 provides a summary of the study variables and 
measures, as well as the assessment time points for each.
Primary outcomes
The primary outcome domains that will be assessed in 
this study are pain intensity and pain tolerance. These 
outcomes will be assessed both at pre- test (T1) and post- 
test (T2) assessment points.
Secondary outcomes
The secondary outcomes to be assessed are psychophysio-
logical indicators of pain- related stress, as reflected by two 
domains: salivary cortisol level and HRV. These outcomes 
will be assessed both at pre- test (T1) and post- test (T2) 
assessment points.
Other variables
Other variables include presumed moderators of the 
effects of at least one intervention on primary and 
secondary outcomes, covariates that are thought to 
potentially bias or affect the effects of interventions 
on outcomes, descriptive and screening variables, and 
manipulation check variables.
Predictors/moderators
Predictor/moderator domains that will be assessed at 
baseline (T0) include hypnotic suggestibility, baseline 
mindfulness, acceptance, pain- related beliefs, religious 
affiliation, religiosity, trait spirituality, previous experi-
ence with CP, SH and MM, outcome expectations and 
trait absorption.
Covariates
Sociodemographic variables that could influence 
outcomes (ie, sex and age) will be assessed at baseline 
(T0), immediately after consent process.
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Descriptive and screening variables
Participants will be asked to provide clinical history infor-
mation (the presence of any acute or chronic illness and/
or health condition, and which) both for determining 
eligibility and describing the sample. Additional demo-
graphic variables (listed in the Measures section) will also 
be assessed at this time to describe the sample.
Manipulation check
An open- ended question (regarding coping strategies 
employed during the CPAW trials to cope with experi-




To assess pain intensity, participants will be asked to rate 
their average pain intensity during the CPAW procedure 
using a 0–10 Numerical Rating Scale (NRS) of pain 
intensity,15 where 0 indicates ‘No pain’ and 10 indicates 
‘Worst imaginable pain’. Previous research supports 
the responsivity of the 0–10 NRS as a measure of pain 
intensity.15 Pain tolerance will be operationalised as 
the length (in seconds) that an individual is willing to 
experience the aversive stimulation, up to a maximum 
of 5 min (300 s). It will be timed by the research using a 
digital stopwatch.
Secondary outcome measures
Salivary cortisol level will be measured using the 
method and kits mentioned above and proposed by 
Schwabe et al.73 Saliva samples will be collected immedi-
ately before and 20 min±30 s after the CPAW.73 Salivary 
Cortisol Luminescence Immunoassay kits (ROCHE, 
Table 2 Assessment points, outcome variables and outcome measures
Variable Measure
Assessment points
Baseline Pre- test (T1) Post- test (T2)
Primary outcomes
  Pain intensity 0–10 Numerical Rating Scale   x x
  Pain tolerance Length (in seconds) that an individual bears 
painful stimulation
  x x
Secondary outcomes         
  Pain- related stress Salivary cortisol level   x x
Heart rate
Predictors/moderators         
  Hypnotic suggestibility Barber Suggestibility Scale x     
  Baseline mindfulness Five- Facet Mindfulness Questionnaire x     
  Acceptance Acceptance and Action Questionnaire- II x     
  Pain- related beliefs Survey of Pain Attitudes x     
  Trait spirituality Spiritual Transcendence Scale x     
  Religious affiliation Multiple choice item: ‘Please indicate your primary 
religious affiliation(s) with the following options, if 
any.’
x     
  Religiosity Duke University Religiosity Index x     
  Previous experience of H, M 
and CP
3 Likert items x     
  Outcome expectations Modified Credibility/Expectancy Questionnaire x     
  Trait absorption Modified Tellegen Absorption Scale x     
Covariates
  Sociodemographic variables Sociodemographic questionnaire x     
Screening variables         
  Clinical history Clinical history questionnaire x     
Manipulation check
  Pain coping response Open- ended item: ‘What did you think or did 
during the experiment to deal/cope with the 
discomfort provoked by the cold?’
  x x
CP, Christian prayer; H, hypnosis; M, meditation.
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Eletroquimioluminescence- Cobas), as well as a lab refrig-
erator to refrigerate the salivary cortisol samples, will be 
used.
Heart rate will also be measured
The recorded ECG will be treated according to the guide-
lines of BIOPAC Systems, in order to optimise the R–R 
interval data for HRV analysis ( www. biopac. com). The 
existence of artefacts and ectopic beats will be monitored. 
The chosen measure of HRV is the high frequency power 
HRV, which is influenced by parasympathetic activity. 
An MP150 BIOPAC system using the software Acqknowl-
edge V.4.0 (BIOPAC Systems) and HRV analysis (http:// 
kubios. uef. fi) will be used to measure heart rate and 
compute HRV and other time and frequency domains.
Measures of predictors/moderators
These will include the following:
Hypnotic suggestibility
Hypnotic suggestibility will be measured using the Barber 
Suggestibility Scale (BSS).74 75 This scale entails eight test 
suggestions (arm lowering, arm levitation, hand lock, 
thirst hallucination, verbal inhibition, body immobility, 
post- hypnotic response and lastly selective amnesia) 
which are scored by the researcher: 1/2 point if there 
are visible signs, and additional 1/2 if the participant 
verbalises afterwards she/he became thirsty. The partici-
pants are also instructed to complete a subjective scoring 
booklet after the administration of the test suggestion, 
relative to the perceived experience with each suggestion. 
These items are answered in a 4- point type of Likert scale, 
from 0 (‘Not light’) to 3 (‘Very light’). Objective scoring 
ranges from 0 to 8, and the subjective score ranges from 
0 to 24, with higher scores indicating higher levels of 
hypnotic suggestibility. The BSS can be applied with or 
without hypnotic induction. In this study it will be used as 
a standard audio- taped hypnotic induction, following the 
script recommend by the authors of the scale.74 The scale 
has shown both validity and reliability in different studies 
with both non- clinical and clinical samples.74 75
Baseline mindfulness
This will be assessed through the Portuguese version of 
the Five- Facet Mindfulness Questionnaire.76 This is a self- 
report questionnaire composed of 39 items divided in 
five domains (observing, describing, acting with aware-
ness, non- judging and non- reactivity), with higher scores 
indicating greater mindfulness capacities. The items are 
answered in a 5- point Likert scale, from 0 (‘Never’) to 
4 (‘Always’). Previous research supports the validity and 
reliability of both the original76 and Portuguese77 versions 
of the Five- Facet Mindfulness Questionnaire.
Acceptance
Acceptance will be measured by using a Portuguese modi-
fied version of the 7- item Acceptance and Action Ques-
tionnaire- II (AAQ- II).78 The items of the 7- item AAQ- II are 
answered in a 7- point type of Likert scale from 1 (‘Never 
true’) to 7 (‘Always true’) that assess a single domain 
of acceptance. Higher scores indicate higher degree of 
acceptance. Previous research supports the validity and 
reliability of the English and Portuguese versions of the 
AAQ- II.78 79
Pain-related beliefs
Pain- related beliefs will be assessed through the Portu-
guese version of the 35- item Survey of Pain Attitudes 
(SOPA-35).80 An official Portuguese version of the 
SOPA-35 is available from the publisher of the SOPA. The 
SOPA-35 is a 35- item self- report questionnaire assessing 
seven pain- related beliefs or domains: pain control, 
disability, medical cure, solicitude, medication, emotion 
and harm. Participants are asked to specify their degree 
of agreement with each statement in a Likert scale from 
0 (‘This is very untrue for me’) to 4 (‘This is very true 
for me’). Seven scores (one per pain- related belief) are 
computed, with higher scores indicating greater agree-
ment with each belief. Previous research supports the 
validity and reliability of the original version of the SOPA-
35.80 The study of the psychometric properties of the 
Portuguese SOPA-35 is in progress.81
Trait spirituality
The Spiritual Transcendence Scale (STS) will be used 
to assess spirituality as trait. The STS consists of 24 items 
divided into 3 domains: prayer fulfilment, universality 
and connectedness.82 Respondents are asked to rate their 
degree of agreement with each statement in a Likert scale, 
from 1 (‘Completely disagree’) to 5 (‘Completely agree’). 
Previous research supports the validity and reliability of 
both the original82 and Portuguese83 versions of the STS.
Religious affiliation
To assess religious affiliation, participants will answer one 
multiple choice question (‘Please indicate your primary 
religious affiliation among the following options, if any’). 
Participants will be asked to choose from a list of possible 
answers: Animist, Buddhist, Christian Anglican, Christian 
Baptist, Christian Calvinist, Christian Lutheran, Christian 
Orthodox, Christian Catholic, Other Christian, Hinduist, 
Islamic, Jewish, Shinto, Taoist, Other, Non- religious 
Agnostic, Non- religious Atheist, None of the previous 
options, Prefer not to answer.
Religiosity
The Duke University Religiosity Index (DUREL) is a 
5- item measure that will be used to assess three major 
dimensions (corresponding the scale’s three domains or 
subscales) of religious involvement: organisational reli-
gious activity, non- organisational religious activity, and 
intrinsic or subjective religiosity.84 Higher scores on the 
three subscales and on the total score of the measure indi-
cate higher religiosity. The original version of this measure 
is a valid and reliable measure of religiosity.84 The study of 
the psychometric properties of the Portuguese version of 
DUREL is in progress. Preliminary findings indicate that 
S
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the Portuguese version of DUREL is valid and reliable in 
a sample of Portuguese individuals with chronic pain.85
Previous experience of SH, MM and CP
To assess previous experience with SH, MM and CP, specif-
ically, participants will be asked to first indicate (yes/no) 
if they have ever practised SH, MM or CP. If the answer is 
‘Yes,’ they will then be asked to indicate how often they 
currently practise SH, MM and CP in 3 Likert items devel-
oped by the research team, from 0 (‘Rarely or never’) to 
4 (‘More than once a day’).
Outcome expectations
A modified version of the Credibility/Expectancy Ques-
tionnaire (CEQ) will be used to measure outcome expec-
tations and rationale credibility relative to each of the 
interventions at the baseline.86 This measure consists of 
6 type of Likert items divided into 2 domains—outcome 
expectations and rationale credibility. Previous research 
supports the validity and reliability of both the original 
version of the CEQ.86 For the purpose of this study, the 
items of the CEQ will be adapted to fit the purposes and 
design of this study. The study of the psychometric prop-
erties of a Portuguese modified version of the CEQ will be 
performed in the context of this study.
Trait absorption
The Modified Tellegen Absorption Scale (MODTAS) will 
be used to assess trait absorption.87 This scale is composed 
of 34- item Likert (from 0—‘never’ to 4—‘very often’) 
divided into 5 domains (synesthesia, altered states of 
consciousness, aesthetic involvement, imaginative involve-
ment, extra- sensory perception) that are grouped in a 
single second- order factor. Previous research supports the 
validity and reliability of the MODTAS.87 88
Measures of covariates
A sociodemographic questionnaire will be developed by 
the research team and will ask participants to provide, 
among others, information regarding their sex and age.
Measures of descriptive and screening variables
A clinical history questionnaire will be developed by the 
research team to assess variables needed to screen the 
participants’ eligibility. This will consist of a list of different 
acute and chronic illnesses and/or health conditions. 
Participants will be asked to indicate the illnesses and/
or health conditions that they currently have. In addition, 
to collect information needed to describe the sample, the 
above- mentioned sociodemographic questionnaire will 
also ask participants to provide information regarding 
their education level, marital status, area of residence, 
employment status, household’s income and religious 
denomination.
Manipulation check
To assess the coping strategies employed by participants 
to cope with the pain induced through CPAW, partici-
pants will answer one open- ended question (‘What did 
you think or did during the experiment to deal/cope 
with the discomfort provoked by the cold?’). Participants 
will be presented this question and asked to provide their 
answer in writing. Answers will be coded by two indepen-
dent researchers who will be blinded to the treatment 
condition, considering if SH, MM, CP or other coping 
strategy were used to cope with the pain.
Assessment procedures
All data collection procedures will be performed by 
a trained research assistant who is blind to the study 
hypotheses and to experimental condition. To maximise 
the quality of the self- report data, only one research assis-
tant will obtain all measures, and this individual will be 
trained by a psychologist experienced in psychological 
questionnaire- based assessment.
Adverse events and safety monitoring
The findings from previous research indicate that 
unanticipated adverse effects associated with either the 
interventions, the CPAW procedures or the assessment 
procedures are unlikely. However, their occurrence will 
be closely monitored and recorded. For example, partic-
ipants may experience fatigue while completing assess-
ments at T0. Participants will also be told they are free to 
skip any questions and stop the assessment at time. Also, 
although participants will likely experience discomfort 
and pain during CPAW procedures (as these are what the 
procedures are designed to induce), they will be told that 
they can discontinue the CPAW procedures at any time 
for any reason they choose, and will also be instructed 
to take off the arm wrap if it feels too uncomfortable for 
them to continue. Given the short duration and minimal 
risks of this study, a formal data monitoring committee 
was deemed unnecessary.
Statistical analysis plan
Results will be considered statistically significant for a 
p value lower than 0.05. Because data collection will be 
completed in person, we do not anticipate significant 
amounts of missing data. In the event that some data are 
missing, missing data analysis will be conducted to deter-
mine potential patterns in missing values or if missing 
values are random. Missing value replacement will be 
performed through the multiple imputation of Markov 
chain Monte Carlo method.89
For analysis of the qualitative data, participants’ 
answers to the manipulation check open- ended question 
will be coded in accordance with a directed qualitative 
approach.90 An initial coding scheme will be developed 
a priori according to past research and used to catego-
rise the units of analysis. Mutually exclusive emerging 
categories concerning the latent and manifest content 
of each pre- existing category (SH, MM, CP, other coping 
strategy) will be identified. The content excerpts (previ-
ously defined as unit of analysis) will be compared with 
the main a priori categories. Complementarily, inductive 
analysis will be conducted in units of analysis that do not 
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fit the theoretically guided categories; for these, induc-
tively created codes will be conceived.91 Coding decisions 
will be assessed by comparing the answers’ excerpts with 
the definitions of the categories and with other answers’ 
excerpts within existing categories. The trustworthiness 
will be assured by the continued comparison in the coding 
process, focusing both theory- guided and inductively 
created categories, but also through the inter- rater reli-
ability coefficient. Thus, at the end of the coding process, 
10% of the questions randomly selected will be coded by 
the two independent researchers, trained in the coding 
matrix and blinded to the treatment condition (consid-
ering if SH, MM, CP or other coping strategy were used to 
cope with the pain). Inter- rater reliability (Cohen’s kappa 
coefficient, j) will be computed, with a j lower than 0 indi-
cating no agreement, a j between 0 and 0.20 indicating 
slight agreement, a j between 0.21 and 0.40 indicating fair 
agreement, a j between 0.41 and 0.60 indicating moderate 
agreement, and a j between 0.61 and 0.80 or higher indi-
cating, respectively, substantial or almost perfect agree-
ment.92 The final coding of the participants’ answers will 
be achieved by consensus. Categories will then be dummy 
coded, with 1 indicating that the participants used a given 
coping strategy and 0 indicating that participants did not 
use a certain coping strategy.
Descriptive statistics (ie, frequencies, percentages, 
means, SDs, as appropriate) will be computed to describe 
the sample and study variables at each assessment point. 
The distributions of the outcome data will also be evalu-
ated (ie, by computing skewness and kurtosis) to deter-
mine if they meet criteria for the planned analyses. If they 
do not, the variables will be transformed (eg, using square 
root transformations) to normalise the data prior to anal-
yses. Then, to test mean differences between four groups 
over the T1 and T2 assessment points, we will perform 
a series of mixed- design repeated- measures analyses of 
variance (ANOVAs), with the four pain- related outcomes 
as dependent variables, and sex, time of assessment (T1 
and T2) and condition as independent variables. Effect 
size measures (partial eta squared) and statistical power 
(1−β) will be computed and reported. If the study vari-
ables do not meet the assumptions for ANOVA analyses 
and cannot be transformed to meet those assumptions, 
we plan to employ the Wilcoxon test.
Secondary exploratory analyses will involve a series of 
hierarchical multiple regression analyses with the four 
outcome variables as the criterion measures, and exper-
imental condition, predictor/moderator variables, time 
and their interactions as independent variables. We will 
examine both direct prediction effects (ie, the extent to 
which the predictor/moderator variables prospectively 
predict outcome across all of the treatment conditions) 
and moderator effects (ie, the extent to which the ability 
of the predictor/moderator variables to predict outcome 
varies as a function of treatment condition). All moder-
ation analyses will consider the entire sample and will 
be done using PROCESS macro for IBM SPSS Statistics 
V.25. We will compute post- hoc correlation coefficients 
(continuous variables) or t- tests (dichotomous variables) 
to help explain any statistically significant moderator (ie, 
Moderator X Condition) effects that emerge. Data anal-
ysis will be conducted using IBM SPSS Statistics V.25.
Patient and public involvement
The development of the research question and choice 
of the outcome measures took into consideration the 
findings from previous findings present in the literature 
regarding the experience of patients with chronic pain 
and regarding the effects of SH, MM, and spiritual and 
religious practices on pain- related outcomes in people 
with chronic pain. The study itself does not involve 
patients. Patients were not directly involved in the devel-
opment of the design of the study. Patients will not be 
involved neither in the recruitment and conduction of 
the study, nor in the assessment of the burden of the 
interventions. Study results will be published in peer- 
reviewed indexed journals and presented at pain interna-
tional scientific meetings. A full report of the study results 
will also be made available at the funding agency website, 
which is open to the public and will be made available to 
study participants.
ETHICS AND DISSEMINATION
The present study was reviewed and approved by ISPA–
University Institute’s internal Ethics Committee for 
Research (ISPA- UI ECR) on 3rd December 2018 (refer-
ence I/010/12/2018). The study will be compliant with 
international ethical principles and guidelines for studies 
involving human subjects. Compliant with Helsinki 
Declaration and with national and European legisla-
tion and with the European Union (EU) General Data 
Protection Regulation (EU Regulation 2016/679 of 27th 
April 2016). Participants will read and sign an informed 
consent form for participation in the study and for data 
collection and storage. The informed consent form will 
include a detailed description of the study aims and 
procedures. Informed consent will be obtained prior to 
any data collection or study procedures. Participants will 
be encouraged to discuss any concerns, any questions 
raised will be addressed by the research team. Partic-
ipants will be assured confidentiality and anonymity. 
Participants’ decision to stop any procedures at any time 
will be honoured.
Data processing activities within the study will be 
carried out in accordance with the updated data protec-
tion rules as specified in the EU General Data Protection 
Regulation which replaces the Data Protection Directive 
95/46/EC. Identifiable information (II) will be linked to 
a unique study participant’s ID. II and the key linking the 
participant ID to the former will be stored in a password- 
protected database, accessible only to the research 
team and staff members. Study data will be coded with 
the participant ID and stored in a password- protected 
computer database. Study data will be accessible only to 
the research team members.
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Any modification to the study protocol will be submitted 
to review and approval of ISPA- UI ECR. Study findings 
will be published in peer- reviewed indexed journals and 
presented at pain international scientific meetings.
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